Literature DB >> 8554839

Variation in prescribing of hypnotics, anxiolytics and antidepressants between 61 general practices.

P D Pharoah1, D Melzer.   

Abstract

BACKGROUND: Although the desirability of reducing prescribing of hypnotics and anxiolytics has long been recognized, variation between practices in patterns of psychotropic drug prescribing has received little attention; factors underlying such variation are poorly understood. AIM: The study aimed to describe the extent of variation between general practices in the prescribing of hypnotics, anxiolytics and antidepressants; it also aimed to analyse the influence of measures of practice population and general practice and general practitioner characteristics on any variation in prescribing volumes.
METHOD: Routinely collected prescribing data and practice population data, from April 1992 to March 1993, from all 61 practices in the Cambridge and Huntingdon Health Commission were analysed. Prescribing was measured as annual defined daily doses per 1000 practice population for each drug class. Data on variables relating to practice structure and general practitioner characteristics were obtained and analysed. Potentially influencing variables were investigated by multiple regression.
RESULTS: Between the highest and lowest prescribing practices there was an 11-fold difference, a 13-fold difference and an eightfold difference in the annual defined daily doses per 1000 practice population prescribed for hypnotics, for anxiolytics and for antidepressants, respectively. Strong positive correlations existed between volumes of prescribing of each drug class. The drugs prescribed in the greatest volumes were hypnotics. Practice population structure had some influence on psychotropic drug prescribing with high prescribing being associated with the proportions of temporary residents and women aged 65 years and over in the practice for all three classes of drug. Other factors, including presence of a practice counsellor, were not found to have a significant influence on psychotropic drug prescribing.
CONCLUSION: The degree of variation in prescribing volumes of psychotropic drugs between practices raises serious concerns. Further study is needed, but progress will be hampered until there is more clarity over the effectiveness and appropriateness of using these substances in the various illness, symptom and life-stress presentations seen in primary care.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8554839      PMCID: PMC1239434     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  19 in total

1.  Pills for personal problems.

Authors:  W H Trethowan
Journal:  Br Med J       Date:  1975-09-27

2.  Use of medicines in general practice.

Authors:  D C Skegg; R Doll; J Perry
Journal:  Br Med J       Date:  1977-06-18

3.  Rural tranquility?: urban-rural differences in tranquilliser prescribing.

Authors:  J Gabe; P Williams
Journal:  Soc Sci Med       Date:  1986       Impact factor: 4.634

4.  Benzodiazepines on trial.

Authors:  P J Tyrer
Journal:  Br Med J (Clin Res Ed)       Date:  1984-04-14

5.  Development of long term use of psychotropic drugs by general practice patients.

Authors:  A Mant; P Duncan-Jones; D Saltman; C Bridges-Webb; L Kehoe; G Lansbury; A H Chancellor
Journal:  Br Med J (Clin Res Ed)       Date:  1988-01-23

6.  Accounting for medical variation: the case of prescribing activity in a New Zealand general practice sample.

Authors:  P B Davis; R L Yee; J Millar
Journal:  Soc Sci Med       Date:  1994-08       Impact factor: 4.634

7.  Drugs and insomnia.

Authors:  J Marks; A N Nicholson
Journal:  Br Med J (Clin Res Ed)       Date:  1984-01-28

8.  A longitudinal study of psychotropic drug prescription.

Authors:  P Williams; J Murray; A Clare
Journal:  Psychol Med       Date:  1982-02       Impact factor: 7.723

Review 9.  Benzodiazepine dependence. A review of the evidence.

Authors:  R T Owen; P Tyrer
Journal:  Drugs       Date:  1983-04       Impact factor: 9.546

10.  Unrecognised depression in general practice.

Authors:  P Freeling; B M Rao; E S Paykel; L I Sireling; R H Burton
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-22
View more
  13 in total

Review 1.  Should general practitioners refer patients with major depression to counsellors? A review of current published evidence. Nottingham Counselling and Antidepressants in Primary Care (CAPC) Study Group.

Authors:  R Churchill; M Dewey; V Gretton; C Duggan; C Chilvers; A Lee
Journal:  Br J Gen Pract       Date:  1999-09       Impact factor: 5.386

2.  Morbidity, deprivation, and antidepressant prescribing in general practice.

Authors:  I F Mackenzie; K Buckingham; J M Wankowski; M Wilcock
Journal:  Br J Gen Pract       Date:  1999-11       Impact factor: 5.386

3.  Relationship between practice counselling and referral to outpatient psychiatry and clinical psychology.

Authors:  J Cape; A Parham
Journal:  Br J Gen Pract       Date:  1998-08       Impact factor: 5.386

4.  Factors influencing variation in prescribing of antidepressants by general practices in Scotland.

Authors:  Jill Morrison; Mary-Jane Anderson; Matt Sutton; Rosalia Munoz-Arroyo; Sara McDonald; Margaret Maxwell; Andrew Power; Michael Smith; Philip Wilson
Journal:  Br J Gen Pract       Date:  2009-02       Impact factor: 5.386

5.  Variations in anxiolytic and hypnotic prescribing by GPs: a cross-sectional analysis using data from the UK Quality and Outcomes Framework.

Authors:  Zoi Tsimtsiou; Mark Ashworth; Roger Jones
Journal:  Br J Gen Pract       Date:  2009-06       Impact factor: 5.386

6.  Clinically significant psychotropic drug-drug interactions in the primary care setting.

Authors:  Brett A English; Marcus Dortch; Larry Ereshefsky; Stanford Jhee
Journal:  Curr Psychiatry Rep       Date:  2012-08       Impact factor: 5.285

7.  Prescription of benzodiazepines in Slovenian family medicine: a qualitative study.

Authors:  Maja Subelj; Gaj Vidmar; Vesna Svab
Journal:  Wien Klin Wochenschr       Date:  2010-07-28       Impact factor: 1.704

8.  Evaluating the safety of mental health-related prescribing in UK primary care: a cross-sectional study using the Clinical Practice Research Datalink (CPRD).

Authors:  Wael Y Khawagi; Douglas Steinke; Matthew J Carr; Alison K Wright; Darren M Ashcroft; Anthony Avery; Richard Neil Keers
Journal:  BMJ Qual Saf       Date:  2021-08-25       Impact factor: 7.418

9.  Antidepressant drug use in general practice: inter-practice variation and association with practice characteristics.

Authors:  Dorte Gilså Hansen; Jens Søndergaard; Werner Vach; Lars Freng Gram; Jens-Ulrik Rosholm; Jakob Kragstrup
Journal:  Eur J Clin Pharmacol       Date:  2003-04-30       Impact factor: 2.953

10.  Variation in prescribing for anxiety and depression: a reflection of health inequalities, cultural differences or variations in access to care?

Authors:  Elizabeth Goyder; Chris Dibben; Michael Grimsley; Jean Peters; Lindsay Blank; Elizabeth Ellis
Journal:  Int J Equity Health       Date:  2006-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.